Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline Summary
- PMID: 29517954
- DOI: 10.1200/JOP.18.00005
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline Summary
Comment in
-
Reply to D.L. Kimpel et al.J Clin Oncol. 2018 Sep 10;36(26):2744. doi: 10.1200/JCO.2018.79.1798. Epub 2018 Jul 18. J Clin Oncol. 2018. PMID: 30020818 No abstract available.
-
Collaboration Between Rheumatology and Oncology in Immune Checkpoint Inhibitor Therapy.J Clin Oncol. 2018 Sep 10;36(26):2743-2744. doi: 10.1200/JCO.2018.79.0428. Epub 2018 Jul 18. J Clin Oncol. 2018. PMID: 30020819 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
